Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADALTA LIMITED Capital/Financing Update 2016

Aug 17, 2016

64247_rns_2016-08-17_bc0207cb-98c2-4d4a-b629-a8254a265bfc.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Notice

Notice reference number: 0979.16.08

==> picture [93 x 8] intentionally omitted <==

----- Start of picture text -----

Notice date: 18/08/2016
----- End of picture text -----

==> picture [541 x 107] intentionally omitted <==

----- Start of picture text -----

What’s this about? Effective date: 18/08/2016
 ASX Trade ASX 24 ASX TECH
 Trading Clearing Settlement ALC ASX NET
Operations Technology Market Data Rules  Compliance Risk  Other
----- End of picture text -----

0BTitle

AdAlta Limited – Admission and Commencement of Official Quotation

1BDescription

AdAlta Limited (the Company) was admitted to the official list of ASX Limited (ASX) on Thursday, 18 August 2016.

Official quotation of the Company’s ordinary shares will commence at 11:45 am AEST on Monday, 22 August 2016. The Company has raised $10,000,000 pursuant to the offer under its prospectus dated 8 July 2016 (Prospectus) by the issue of 40,000,000 million ordinary shares at an issue price of $0.25 per share.

Quoted Securities: 76,425,758 fully paid ordinary shares ASX Code: 1AD Time: 11:45 am AEST Date: Monday, 22 August 2016 ASX Trade Abbreviation: ADALTA ISIN: AU0000001AD2 Home Branch: Melbourne Industry Classification: GICS 3520 – Pharmaceuticals, Biotechnology and Life Sciences Corporate Office: 15/2 Park Drive, Bundoora, VIC 3083 Phone: (03) 9479 5159 Website: www.adalta.com.au Communication person with Samantha Kathleen Cobb ASX: Share Registry: Automic Registry Services Suite 310, Level 3, 50 Holt Street Surrey Hills, NSW 2010

1/2

(continued)

ASX Notice

Balance Date: 30 June
CHESS: Participating. The Company will also operate an issuer sponsored sub-register.
State of incorporation: Victoria
Activities: Drug discovery and development
Dividend Policy: See page 49 of the Prospectus
Joint Lead Managers: Patersons Securities Limited AFSL
ASX Restricted Securities: 22,997,291 fully paid ordinary shares escrowed for a period of 24 months from the date of
official quotation.
1,406,241 options exerciseable at various prices expiring various dates escrowed for a period
of 24 months from the date of official quotation.
576,967 fully paid ordinary shares escrowed until 23 February 2017.
Securities not quoted: 738,182 options exerciseable at various prices expiring various dates.

What do I need to do and by when?

2BInstructions

Please refer to the Company’s Prospectus and website for further information.

Need more information?

For further information, please contact the share registry between 9.00 AM AEST and 5.00 pm AEST on 1300 288 664 or +61 2 9698 5414 or by email to [email protected]

Issued by Kate Kidson

5Disclaimer

2/2